top of page

Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
Allogenica received a €2.5 million grant from the French government 's France 2030 program to support the industrialization of its...
Mar 19

Allogenica Strengthens Management Team to Drive Growth and Innovation
New Leadership Appointments: Allogenica appoints Tobias Abel, PhD, formerly with Sangamo Therapeutics, as Chief Scientific Officer and...
Nov 19, 2024

Don't miss the opportunity to connect with Allogenica at the 9th CAR-TCR Summit in Boston, MA, September 17-20, 2024
Connect with Inna Menkova at the 9th CAR-TCR Summit
Sep 3, 2024

1-year milestones reached for R&D collaborative project with CRCL
We are pleased to announce that the R&D collaborative projet between Allogenica and its academic partner Dr Julien MARIE’s team, based in...
May 6, 2024

Advanced Therapies' congress 2024
Allogenica was representerd in London 19-20 March, 2024 for the Advanced Therapies congress.
May 6, 2024


iVenture/Tech&Fest 2024
Allogenica was represented in Grenoble for iVenture and Tech&Fest on February 1-2, 2024. Dr Inna Menkova, CEO, presented the company to...
May 6, 2024


New facilities for Allogenica at Bioparc Rockefeller in Adenine Building
This is a significant milestone in Allogenica's journey, characterized by enlarged Laboratory space, specially designed to host our...
Jan 10, 2024

Allogenica awarded with the Innovation trophy from VCLS Innovation Center
Allogenica's heart and soul is innovation. The innovation that we wish to bring to patients by developing allogeneic CAR-T immediately...
Dec 19, 2023


Clara “proof of concept” winner
We are honored to be Clara “proof of concept” recipient. This project arose from interactions between Dr. Inna MENKOVA and Dr. Julien...
Jul 27, 2023


Inna MENKOVA awarded the "Femme de la Tech" prize
Inna MENKOVA, CEO of Allogenica, was yesterday awarded the "Femme de la Tech" prize at the 20th edition of the "Décideures" competition...
May 1, 2023


Allogenica, winner of the 2023 Hello Tomorrow Global Challenge
Inna MENKOVA, CEO of Allogenica, was honored to receive the « Medical biotech & pharmaceuticals » award and to be in the top 3 finalists...
Mar 13, 2023

Allogenica, winner of the national i-Lab 2022 competition
Yesterday, Allogenica's co-founders Inna MENKOVA and Jean-Guillaume Lafay went to Cité des sciences et de l'industrie to receive and...
Oct 10, 2022


The biotech company Allogenica has secured €500,000 investment from renowned investors to advance innovative biotherapies for cancers.
Founded in January 2022, Allogenica is dedicated to developing universal CAR-T cell-therapies to treat cancers, particularly blood...
Sep 5, 2022


The start-up Allogenica is developing innovative biotherapies for blood cancers.
Founded in January 2022, Allogenica specialized in the development of universal Chimeric Antigen Receptor T-cell-therapies (CAR-T...
Mar 24, 2022
bottom of page